Your browser doesn't support javascript.
loading
Controversies, Consensus, and Collaboration in the Use of 131I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association.
Tuttle, R Michael; Ahuja, Sukhjeet; Avram, Anca M; Bernet, Victor J; Bourguet, Patrick; Daniels, Gilbert H; Dillehay, Gary; Draganescu, Ciprian; Flux, Glenn; Führer, Dagmar; Giovanella, Luca; Greenspan, Bennett; Luster, Markus; Muylle, Kristoff; Smit, Johannes W A; Van Nostrand, Douglas; Verburg, Frederik A; Hegedüs, Laszlo.
Afiliación
  • Tuttle RM; 1 Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Ahuja S; 2 Evidence and Quality, Society of Nuclear Medicine and Molecular Imaing, Reston, Virginia.
  • Avram AM; 3 Division of Nuclear Medicine, Department of Radiology, University of Michigan Medical Center, Ann Arbor, Michigan.
  • Bernet VJ; 4 Division of Endocrinology, Mayo Clinic College of Medicine, Jacksonville, Florida.
  • Bourguet P; 5 Department of Nuclear Medicine, University Hospital of Martinique, Fort de France, Martinique.
  • Daniels GH; 6 University of Antilles, Pointe-à-Pitre, Guadeloupe.
  • Dillehay G; 7 Thyroid Unit, Massachusetts General Hospital, Boston, Massachusetts.
  • Draganescu C; 8 Department of Nuclear Medicine, Northwestern Memorial Hospital, Chicago, Illinois.
  • Flux G; 5 Department of Nuclear Medicine, University Hospital of Martinique, Fort de France, Martinique.
  • Führer D; 9 Department of Physics, Royal Marsden Hospital and Institute of Cancer Research, Sutton, United Kingdom.
  • Giovanella L; 10 Department of Endocrinology and Metabolism, University Hospital Essen, Essen, Germany.
  • Greenspan B; 11 Clinic of Nuclear Medicine and Thyroid Center, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
  • Luster M; 12 Clinic for Nuclear Medicine, University of Zürich, Zürich, Switzerland.
  • Muylle K; 13 North Augusta, South Carolina.
  • Smit JWA; 14 Department of Nuclear Medicine, University Hospital Marburg, Marburg, Germany.
  • Van Nostrand D; 15 Department of Nuclear Medicine, University Hospital Brussels (UZ Brussel, VUB), Brussels, Belgium.
  • Verburg FA; 16 European Association of Nuclear Medicine, Vienna, Austria.
  • Hegedüs L; 17 Department of Endocrinology, Radboud University Medical Center, Nijmegen, The Netherlands.
Thyroid ; 29(4): 461-470, 2019 04.
Article en En | MEDLINE | ID: mdl-30900516
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Diferenciación Celular / Oncología por Radiación / Radiofármacos / Radioisótopos de Yodo Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Humans Idioma: En Revista: Thyroid Asunto de la revista: ENDOCRINOLOGIA Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Diferenciación Celular / Oncología por Radiación / Radiofármacos / Radioisótopos de Yodo Tipo de estudio: Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Humans Idioma: En Revista: Thyroid Asunto de la revista: ENDOCRINOLOGIA Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos